MA24.09 Synergy Between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small Cell Lung Cancer With an Altered Metabolism

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.526
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2006English

Emerging Roles of Nrf2 Signal in Non-Small Cell Lung Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

Comparison of Primary Tumor SUVmax Between Small Cell Lung Cancer and Non-Small Cell Lung Cancer

Current Trends in Clinical & Medical Imaging
2019English

miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2020English

The ACSL3-LPIAT1 Signaling Drives Prostaglandin Synthesis in Non-Small Cell Lung Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2020English

Cancer Stem Cells in Lung Cancer: Distinct Differences Between Small Cell and Non-Small Cell Lung Carcinomas

2011English

A Novel Imidazopyridine PI3K Inhibitor With Anticancer Activity in Non-Small Cell Lung Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2013English

Proteomic Profiling Identifies Pathways Dysregulated in Non-Small Cell Lung Cancer and an Inverse Association of AMPK and Adhesion Pathways With Recurrence

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2010English

Non-Small Cell Lung Cancer

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy